Pascale Witz - PerkinElmer Independent Director
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
Director
Ms. Pascale Witz is the director of the company. she served as director since 2017. Ms. Witz has served as the Chief Executive Officer of PWH Advisors, a consulting services firm for healthcare companies, since founding the firm in 2016. Previously, Ms. Witz served as the Executive Vice President, Diabetes Cardiovascular for Sanofi, S.A. from September 2015 through May 2016, having formerly held the position of Executive Vice President, Global Divisions and Strategic Development for Sanofi from July 2013. Before joining Sanofi, Ms. Witz was employed in positions of increasing responsibility with GE Healthcare starting in 1996, most recently serving as the President and Chief Executive Officer of Medical Diagnostics from March 2009 through June 2013. Ms. Witz currently serves on the boards of Horizon Pharma Plc, Regulus Therapeutics, Inc. and Fresenius Medical Care AG Co. KGaA, and formerly served on the boards of Savenica SA and TESARO, Inc. She is also a director of the notforprofit FrenchAmerican Foundation France and the Global Alzheimers Platform Foundation. Ms. Witz received her MS degree in biochemistry from the Institut National des Sciences Appliques de Lyon, France and her MBA degree from INSEAD, Fontainebleau, France. She was also a doctoral student in molecular biology at the Centre National de la Recherche Scientifique, Strasbourg, France since 2017.
| Age | 54 |
| Tenure | 7 years |
| Phone | 781 663 6900 |
| Web | https://www.perkinelmer.com |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.PerkinElmer has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for PerkinElmer to invest in growth at high rates of return.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Carol Burt | IQVIA Holdings | 62 | |
| Elisha Finney | Mettler Toledo International | 59 | |
| John Leonard | IQVIA Holdings | 62 | |
| James Fasano | IQVIA Holdings | 50 | |
| Lars Sorensen | Thermo Fisher Scientific | 67 | |
| Deborah Kochevar | Charles River Laboratories | 64 | |
| Robert Bertolini | Charles River Laboratories | 59 | |
| Gary Hendrickson | Waters | 64 | |
| James Mullen | Thermo Fisher Scientific | 62 | |
| JeanLuc Belingard | Laboratory of | 72 | |
| Hans Bishop | Agilent Technologies | 56 | |
| Nancy Andrews | Charles River Laboratories | 63 | |
| Francis deSouza | Illumina | 53 | |
| Mala Anand | Agilent Technologies | 53 | |
| Debora Spar | Thermo Fisher Scientific | 56 | |
| Michael Kelly | Mettler Toledo International | 64 | |
| Michael Berendt | Waters | 71 | |
| Nelson Chai | Thermo Fisher Scientific | 55 | |
| Ronald Rittenmeyer | IQVIA Holdings | 73 | |
| Caspar Tudor | Waters | N/A | |
| R Keith | Thermo Fisher Scientific | 52 | |
Management Performance
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
| Samuel Chapin, Independent Director | ||
| Michel Vounatsos, Independent Director | ||
| James Mock, Chief Financial Officer, Senior Vice President | ||
| Sylvie Gregoire, Independent Director | ||
| Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
| Pascale Witz, Independent Director | ||
| Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
| Peter Barrett, Independent Director | ||
| Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
| Frank Witney, Independent Director | ||
| Alexis Michas, Independent Non-Executive Chairman of the Board | ||
| Stephen Willoughby, VP ESG | ||
| Tajinder Vohra, Senior Vice President Global Operations | ||
| Prahlad Singh, Senior Vice President and President - Diagnostics | ||
| Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
| Maxwell Krakowiak, VP CFO | ||
| Masoud Toloue, VP Diagnostics | ||
| Daniel Tereau, Senior Vice President Strategy and Business Development | ||
| Alexandros Michas, Independent Non-Executive Chairman of the Board |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |